Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-04 04:01:04 - browse：174

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Lung cancer screening guidelines updated for cigarette smokers

leisure time

WSS

Live blog: Hearing on CRISPR

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

VC firm RA Capital starts a new synthetic biology incubator

Life sciences investors close nearly $6 billion in new funds

Trump allegedly attempted to have surveillance video deleted: Special Counsel

focus

Wikipedia

knowledge

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Alkermes shareholders re

How to convince healthy people to buy insurance

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The mammogram wars are not over

The cancer drug shortage isn’t new — and neither are the solutions

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Heart attack and stroke risk calculators need revising

Inari Medical to buy amputation prevention company LimFlow

focus

How neuroscience research could help beat back brain cancer

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

The health care issue Democrats can’t solve: hospital reform

As the dark side of IVF slowly comes into focus, even more transparency is needed

Biden announces an advanced cancer research initiative

focus

leisure time

explore

hotspot